Orna Therapeutics Welcomes Joseph Bolen, Ph.D. as New CEO to Lead Innovative Cancer and Autoimmune Treatments Orna Therapeutics has appointed Joseph Bolen, Ph.D. as CEO to guide the company in its clinical trials for innovative RNA therapies targeting cancer and autoimmune diseases.

Orna Therapeutics Welcomes Joseph Bolen, Ph.D. as New CEO to Lead Innovative Cancer and Autoimmune Treatments #United_States #Watertown #Orna_Therapeutics #Biotech_Innovation #Joseph_Bolen